• Most Popular
  • Most Shared

CORRECTING and REPLACING Cross Country Healthcare Reports Third Quarter 2009 Results

Mon Nov 2, 2009 6:27pm EST

http://www.businesswire.com/news/home/20091102006391/en

BOCA RATON, Fla.--(Business Wire)--
The only correction is to include the second table header: 

Cross Country Healthcare, Inc.
Condensed Consolidated Balance Sheets
(Unaudited, amounts in thousands) 

The corrected release reads: 

CROSS COUNTRY HEALTHCARE REPORTS THIRD QUARTER 2009 RESULTS

Cross Country Healthcare, Inc. (Nasdaq: CCRN) today reported revenue of $129.6
million in the third quarter ended September 30, 2009, a 27% decrease from
revenue of $178.1 million in the prior year quarter. Net income for the third
quarter of 2009 was $1.0 million, or $0.03 per diluted share, a decline of 84%
compared to net income of $6.2 million, or $0.20 per diluted share, in the prior
year quarter. On a sequential basis, revenue decreased 13% from the second
quarter of 2009, while net income decreased 58%. Cash flow from operations for
the third quarter of 2009 was $19.5 million. 

For the nine months ended September 30, 2009, the Company generated revenue of
$454.1 million and net income of $6.3 million, or $0.20 per diluted share. This
compares to revenue of $528.3 million and net income of $18.4 million, or $0.59
per diluted share, in the first nine months of the prior year. Cash flow from
operations for the first nine months of 2009 was $69.9 million. 

"The improvement in contract bookings activity within our nurse and allied
staffing business that we first noted in our second quarter earnings release in
August is continuing. Keep in mind that it takes several months for sequential
volume growth to materialize after booking trends begin to improve due to the
typical three-month contract length and the normal one-month delay from the time
a contract is booked to the assignment start," said Joseph A. Boshart, President
and Chief Executive Officer of Cross Country Healthcare, Inc. "While it took
most of the third quarter to halt the negative momentum of our staffing volume
resulting from the extraordinary weakness in demand during the months leading up
to this summer, since mid-September our travel staffing volume has increased 6%.
This improvement in staffing volume has resulted from a significant increase in
demand since the spring, with current open order levels for travel nurses six
times the levels seen prior to the summer," he said. 

Mr. Boshart continued, "Our analysis of the increase in demand indicates that it
is spread across numerous nursing specialties and suggests the increase is not
just related to the H1N1 virus or normal seasonality, which leads us to believe
it should be sustainable. While we do not expect our staffing volume to parallel
the rapid increase in demand, it does change the constraint on our growth from
one of demand to one of supply. So the primary challenge we now face is a more
familiar one to us - recruiting enough qualified nurses to meet increasing
demand for contract nursing services." 

"Our other businesses, which include physician staffing and clinical trials
services, are also exhibiting varying degrees of stabilization to the extent
that we can say with some confidence that we believe the trough in our business
activity will be the second half of 2009. Moreover, as a result of effective
margin management, cost controls and a reduction of receivables, our strong cash
flow has allowed us to de-lever our balance sheet by $75 million in the past
twelve months. During the third quarter alone we reduced our debt outstanding by
$24 million," said Mr. Boshart. 

Nurse and Allied Staffing 

For the third quarter of 2009, the nurse and allied staffing business segment
(travel and per diem nurse and travel allied staffing) generated revenue of
$64.1 million, reflecting a 50% decrease from the prior year quarter and an 18%
decrease sequentially from the second quarter of 2009. Contribution income
(defined as income from operations before depreciation and amortization,
impairment charges and corporate expenses not specifically identified to a
reporting segment) decreased 56% in the third quarter of 2009 to $6.2 million
from $14.3 million in the same quarter a year ago, and decreased 13%
sequentially from the second quarter of 2009. The decreases in revenue and
contribution income reflect a sharp decline in demand for temporary nurse and
allied staffing services from a year ago primarily due to the economic
environment and its impact on the national labor market. 

Segment staffing volume decreased 48% from the prior year quarter and 19%
sequentially from the second quarter of 2009. The average revenue per FTE per
week for the third quarter of 2009 declined 3.5% from the prior year quarter due
to a higher mix of per diem staffing coupled with a change in the mix within per
diem to lower-skilled professionals. The average hourly bill rate in the travel
nurse staffing business was essentially flat year-over-year. 

For the first nine months of 2009, segment revenue decreased 38% on a
year-over-year basis to $247.7 million from $402.2 million in the same period a
year ago, while contribution income decreased 43% to $23.5 million from $41.1
million in the prior year period. 

Physician Staffing 

For the third quarter of 2009, the physician staffing business segment generated
revenue of $39.6 million, a 3% decrease sequentially from the second quarter of
2009, while contribution income in the third quarter of 2009 was $4.0 million, a
4% decrease sequentially from the second quarter of 2009. Physician staffing
days filled for the third quarter of 2009 were 24,395 days, a pro forma decrease
of 13% from the prior year quarter. Revenue per day filled for the third quarter
of 2009 was $1,651, a pro forma 4% increase from the prior year quarter,
reflecting a favorable change in the mix of business. 

The Company believes the recession, the stock market decline and the weakened
housing market appear to have delayed the retirement plans of many older
physicians. This dynamic, in conjunction with fewer elective surgeries, has
resulted in a decrease in demand for temporary physicians, particularly in such
specialties as anesthesiology and surgery. 

For the first nine months of 2009, segment revenue was $118.6 million and
contribution income was $11.3 million. No meaningful prior period comparisons
are available as the Company acquired its physician staffing business in
September of 2008. 

Clinical Trials Services 

For the third quarter of 2009, the clinical trials services segment generated
revenue of $16.4 million, a decrease of 35% from $25.4 million in the prior year
quarter and a decrease of 15% sequentially from the second quarter of 2009.
Contribution income decreased 56% in the third quarter of 2009 to $1.7 million
from $3.8 million in the prior year and decreased 27% sequentially from the
second quarter of 2009. 

The environment for clinical trials services has been weak during the year
stemming from a slow-down in clinical trials caused largely by economic factors
and financial market conditions, along with uncertainty concerning R&D
activities following mergers and acquisitions in the pharmaceutical and
biotechnology sectors. The Company is seeing gradual improvement in the core
contract staffing component of its business while continuing to experience
weakness in its other service offerings due to project-specific factors in its
CRO activities and in drug safety monitoring activities. 

For the first nine months of 2009, segment revenue decreased 24% on a
year-over-year basis to $56.8 million from $75.2 million in the same period a
year ago, while contribution income decreased 49% to $6.1 million from $11.9
million in the prior year period. 

Other Human Capital Management Services 

For the third quarter of 2009, the other human capital management services
business segment (education and training and retained search) generated revenue
of $9.6 million, a 26% decrease from revenue of $13.0 million in the same
quarter in the prior year, reflecting a lower number of retained searches and
lower average seminar attendance. Segment contribution income decreased 57% to
$0.7 million in the third quarter of 2009 from $1.6 million in the prior year
quarter primarily as a result of weakness in the retained physician search
business. On a sequential basis, segment revenue decreased 7% while contribution
income increased 107% from the second quarter of 2009. 

For the first nine months of 2009, segment revenue decreased 23% on a
year-over-year basis to $31.0 million from $40.1 million in the same period a
year ago, while contribution income decreased 68% to $1.9 million from $6.1
million in the prior year period. 

Debt Repayments 

During the third quarter of 2009, the Company reduced borrowings on its debt
outstanding by $23.6 million from the end of the prior quarter. At September 30,
2009, the Company had $69.5 million of total debt on its balance sheet and a
debt, net of cash, to total capitalization ratio of 18.4%. At the end of the
third quarter of 2009, the Company`s debt leverage ratio (as defined in its
credit agreement) was 1.7 to 1, which is well under the 2.5 to 1 maximum
allowable ratio that became effective September 30, 2009, and remains in effect
for the duration of the credit agreement, which expires in September 2013.
Subsequent to the end of the third quarter, the Company made a $3.0 million
optional pre-payment on its term debt as a result of its continued strong cash
flow. 

Fourth Quarter 2009 Guidance 

The following statements are based on current management expectations. Such
statements are forward-looking and actual results may differ materially. These
statements do not include the potential impact of any future mergers,
acquisitions or other business combinations, any impairment charges or valuation
allowances, any significant legal proceedings or repurchases of the Company's
common stock. 

Cross Country Healthcare expects revenue in the fourth quarter of 2009 to be in
the $120 million to $123 million range and earnings per diluted share to be in
the range of $0.02 to $0.04. For the full year ended December 31, 2009, the
Company expects revenue to be in the $574 million to $577 million range and
earnings per diluted share to be in the range of $0.22 to $0.24. 

Quarterly Conference Call 

Cross Country Healthcare will hold a conference call on Tuesday, November 3rd at
10:00 a.m. Eastern Time to discuss its third quarter 2009 financial results.
This call will be webcast live and may be accessed at the Company's website at
www.crosscountryhealthcare.com or by dialing 888-947-9022 from anywhere in the
U.S. or by dialing 415-228-4733 from non-U.S. locations - Passcode: Cross
Country. A replay of the webcast will be available from November 3rd through
November 17th. A replay of the conference call will be available by telephone
from approximately noon Eastern Time on November 3rd until November 17th by
calling 866-470-7050 from anywhere in the U.S. or 203-369-1484 from non-U.S.
locations - Passcode: 2009. 

About Cross Country Healthcare 

Cross Country Healthcare, Inc. is a diversified leader in healthcare staffing
services. The Company offers a comprehensive suite of staffing and outsourcing
services to the healthcare market, which together include being a leading
national provider of nurse and allied staffing services and multi-specialty
physician staffing services; a provider of clinical trials services to global
pharmaceutical and biotechnology customers; and a provider of other human
capital management services focused on healthcare. The Company has more than
5,000 contracts with hospitals and healthcare facilities, pharmaceutical and
biotechnology customers, and other healthcare organizations. Copies of this and
other news releases as well as additional information about Cross Country
Healthcare can be obtained online at www.crosscountryhealthcare.com.
Shareholders and prospective investors can also register at the corporate
website to automatically receive the Company's press releases, SEC filings and
other notices by e-mail. 

In addition to historical information, this press release contains statements
relating to our future results (including certain projections and business
trends) that are "forward-looking statements" within the meaning of Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and are subject to the
"safe harbor" created by those sections. Forward-looking statements consist of
statements that are predictive in nature, depend upon or refer to future events.
Words such as "expects", "anticipates", "intends", "plans", "believes",
"estimates", "suggests", "seeks", "will" and variations of such words and
similar expressions intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results and performance to be materially
different from any future results or performance expressed or implied by these
forward-looking statements. These factors include, without limitation, the
following: our ability to attract and retain qualified nurses, physicians and
other healthcare personnel, costs and availability of short-term housing for our
travel nurses and physicians, demand for the healthcare services we provide,
both nationally and in the regions in which we operate, the functioning of our
information systems, the effect of existing or future government regulation and
federal and state legislative and enforcement initiatives on our business, our
clients` ability to pay us for our services, our ability to successfully
implement our acquisition and development strategies, the effect of liabilities
and other claims asserted against us, the effect of competition in the markets
we serve, our ability to successfully defend the Company, its subsidiaries, and
its officers and directors on the merits of any lawsuit or determine its
potential liability, if any, and other factors set forth in Item 1A. "Risk
Factors" in the Company`s Annual Report on Form 10-K for the year ended December
31, 2008, and our other Securities and Exchange Commission filings made during
2009.

Although we believe that these statements are based upon reasonable assumptions,
we cannot guarantee future results and readers are cautioned not to place undue
reliance on these forward-looking statements, which reflect management`s
opinions only as of the date of this press release. There can be no assurance
that (i) we have correctly measured or identified all of the factors affecting
our business or the extent of these factors` likely impact, (ii) the available
information with respect to these factors on which such analysis is based is
complete or accurate, (iii) such analysis is correct or (iv) our strategy, which
is based in part on this analysis, will be successful. The Company undertakes no
obligation to update or revise forward-looking statements. All references to
"we," "us," "our," or "Cross Country" in this press release mean Cross Country
Healthcare, Inc., its subsidiaries and affiliates.

                                                                                                                                                                                                                  
                                                  Cross Country Healthcare, Inc.                                                                                                                                 
                                                  Consolidated Statements of Income                                                                                                                              
                                                  (Unaudited, amounts in thousands, except per share data)                                                                                                       
                                                                                                                                                                                                     
                                                  Three Months Ended                                                                Nine Months Ended                                                    
                                                  September 30,                                                                     September 30,                                                        
                                                        2009                       2008          % Change                           2009                    2008               % Change       
                                                                                                                                                                                                     
                                                                                                                                                                                                     
 Revenue from services                            $     129,635              $     178,134       (27    %)                    $    454,098            $    528,336            (14    %)     
 Operating expenses:                                                                                                                                                                                 
 Direct operating expenses                              94,281                     130,696       (28    %)                         332,890                 390,081            (15    %)     
 Selling, general and administrative expenses           28,858                     33,475        (14    %)                         96,325                  97,763             (1     %)     
 Bad debt expense                                       (303     )                 203           (249   %)                         (227     )              687                (133   %)     
 Depreciation                                           2,034                      1,789         14     %                          6,645                   5,352              24     %      
 Amortization                                           1,005                      713           41     %                          3,046                   2,029              50     %      
 Total operating expenses                               125,875                    166,876       (25    %)                         438,679                 495,912            (12    %)     
 Income from operations                                 3,760                      11,258        (67    %)                         15,419                  32,424             (52    %)     
 Other expenses (income):                                                                                                                                                                            
 Foreign exchange loss (gain)                           18                         (79)          123    %                          31                      (119     )         126    %      
 Interest expense, net                                  1,664                      788           111    %                          4,878                   1,960              149    %      
 Other income                                           (193     )                 -             ND                                 (193     )              -                  ND             
 Income before income taxes                             2,271                      10,549        (78    %)                         10,703                  30,583             (65    %)     
 Income tax expense                                     1,303                      4,378         (70    %)                         4,407                   12,191             (64    %)     
 Net income                                       $     968                  $     6,171         (84    %)                    $    6,296              $    18,392             (66    %)     
                                                                                                                                                                                                     
 Net income per common share:                                                                                                                                                                        
 Basic                                            $     0.03                 $     0.20          (85    %)                    $    0.20               $    0.60               (67    %)     
 Diluted                                          $     0.03                 $     0.20          (85    %)                    $    0.20               $    0.59               (66    %)     
                                                                                                                                                                                                     
 Weighted average common shares outstanding:                                                                                                                                                            
 Basic                                                  30,814                     30,710                                           30,793                  30,842                            
 Diluted                                                31,002                     30,911                                           30,963                  31,032                            
                                                                                                                                                                                                     
 ND - Not determinable                                                                                                                                                                               


                                                                                                              
                                               Cross Country Healthcare, Inc.                                  
                                               Condensed Consolidated Balance Sheets                           
                                               (Unaudited, amounts in thousands)                               
                                                                                                             
                                               September 30,                      December 31,               
                                               2009                               2008                       
 Assets                                                                                                      
 Current assets:                                                                                             
 Cash and cash equivalents                     $       12,003                   $       10,173           
 Restricted cash                                       -                                5,000            
 Accounts receivable, net                              70,316                           117,794          
 Deferred tax assets                                   11,911                           11,287           
 Income taxes receivable                               -                                977              
 Other current assets                                  8,629                            16,149           
 Total current assets                                  102,859                          161,380          
 Property and equipment, net                           21,481                           25,985           
 Trademarks, net                                       64,557                           64,443           
 Goodwill, net                                         130,698                          122,598          
 Other identifiable intangible assets, net             29,568                           32,459           
 Debt issuance costs, net                              1,800                            2,676            
 Other long-term assets                                16,799                           16,309           
 Total assets                                  $       367,762                  $       425,850          
                                                                                                             
 Liabilities and Stockholders' Equity                                                                        
 Current liabilities:                                                                                        
 Accounts payable and accrued expenses         $       8,539                    $       12,440           
 Accrued employee compensation and benefits            17,602                           21,334           
 Current portion of long-term debt                     5,863                            15,826           
 Income taxes payable                                  2,248                            -                
 Other current liabilities                             7,095                            6,682            
 Total current liabilities                             41,347                           56,282           
                                                                                                             
 Long-term debt                                        63,619                           117,255          
 Interest rate swaps                                   1,811                            2,382            
 Other long-term liabilities                           17,568                           15,908           
 Total liabilities                                     124,345                          191,827          
                                                                                                             
 Commitments and contingencies                                                                               
                                                                                                             
 Stockholders' equity:                                                                                       
 Common stock                                          3                                3                
 Additional paid-in capital                            238,909                          237,372          
 Accumulated other comprehensive loss                  (3,273   )                       (4,834   )       
 Retained earnings                                     7,778                            1,482            
 Total stockholders' equity                            243,417                          234,023          
                                                                                                             
 Total liabilities and stockholders' equity    $       367,762                  $       425,850          


                                                                                                                                                                                                                                                                       
                                            Cross Country Healthcare, Inc.                                                                                                                                                                                             
                                            Segment Data (a)                                                                                                                                                                                                           
                                            (Unaudited, amounts in thousands)                                                                                                                                                                                          
                                                                                                                                                                                                                                                 
                                            Three Months Ended                                                                                          Nine Months Ended                                                                                      
                                            September 30,                                                                                               September 30,                                                                                          
                                                2009         % of Total               2008         % of Total           % Change                     2009         % of Total                 2008         % of Total              % Change       
                                                                                                                                                                                                                                                 
 Revenue:                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                 
 Nurse and allied staffing                  $   64,053       49      %           $   128,910      73      %           (50  %)                $   247,664      54   %              $   402,241      76    %               (38    %)     
 Physician staffing                             39,595       31      %               10,831       6       %           NM                         118,600      26   %                  10,831       2     %               NM            
 Clinical trials services                       16,426       13      %               25,414       14      %           (35  %)                    56,816       13   %                  75,181       14    %               (24    %)     
 Other human capital management services        9,561        7       %               12,979       7       %           (26  %)                    31,018       7    %                  40,083       8     %               (23    %)     
                                            $   129,635      100     %           $   178,134      100     %           (27  %)                $   454,098      100  %              $   528,336      100   %               (14    %)     
                                                                                                                                                                                                                                                 
 Contribution income (b)                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                 
 Nurse and allied staffing                  $   6,236                             $   14,332                            (56  %)                $   23,466                            $   41,132                              (43    %)     
 Physician staffing                             3,961                                 928                               NM                         11,334                                928                                 NM            
 Clinical trials services                       1,652                                 3,755                             (56  %)                    6,111                                 11,937                              (49    %)     
 Other human capital management services        682                                   1,589                             (57  %)                    1,940                                 6,092                               (68    %)     
                                                12,531                                20,604                            (39  %)                    42,851                                60,089                              (29    %)     
                                                                                                                                                                                                                                                 
 Unallocated corporate overhead                 5,732                                 6,844                             (16  %)                    17,741                                20,284                              (13    %)     
 Depreciation                                   2,034                                 1,789                             14   %                     6,645                                 5,352                               24     %      
 Amortization                                   1,005                                 713                               41   %                     3,046                                 2,029                               50     %      
 Income from operations                     $   3,760                             $   11,258                            (67  %)                $   15,419                            $   32,424                              (52    %)     


                                                                                                                                                          
                                                                   Cross Country Healthcare, Inc.                                                         
                                                                   Other Financial Data                                                                   
                                                                   (Unaudited)                                                                            
                                                                                                                                                    
                                                                   Three Months Ended                         Nine Months Ended                         
                                                                   September 30,                              September 30,                             
                                                                         2009                2008               2009                 2008       
 Net cash provided by operating activities (in thousands)          $     19,466        $     13,760       $     69,876         $     40,932     
                                                                                                                                                    
 Nurse and allied staffing statistical data:                                                                                                        
 FTEs (c)                                                                2,234               4,335              2,876                4,566      
 Weeks worked (d)                                                        29,042              56,355             112,164              178,074    
 Average nurse and allied staffing revenue per FTE per week (e)    $     2,206         $     2,287        $     2,208          $     2,259      
                                                                                                                                                             
 (a) Segment data provided is in accordance with the Segment Reporting Topic of the Financial Accounting Standards Board Accounting Standards Codification.  
 (b) Defined as income from operations before depreciation, amortization, impairment charges and corporate expenses not specifically identified to a reporting segment.  Contribution income is a financial measure used by management when assessing segment performance. 
 (c) FTEs represent the average number of nurse and allied contract staffing personnel on a full-time equivalent basis.                                      
 (d) Weeks worked is calculated by multiplying the FTEs by the number of weeks during the respective period.                                                 
 (e) Average revenue per FTE per week is calculated by dividing the nurse and allied staffing revenue by the number of weeks worked in the respective periods.  Nurse and allied staffing revenue also includes revenue from permanent placement of nurses. 


Cross Country Healthcare, Inc.
Howard A. Goldman, Director/Investor & Corporate Relations
877-686-9779
Email: hgoldman@crosscountry.com



Copyright Business Wire 2009



More from Reuters

HIV infected boy Gao Jun, 8, holds in his hands antiretroviral drugs used in the treatment of HIV, in an orphanage run by the Fuyang AIDS Orphan Salvation Association in Fuyang, Anhui province November 27, 2009.   REUTERS/Aly Song

Special Report: Insurer drops coverage for HIV patients

When Jerome Mitchell successfully sued his insurance company after it revoked his policy, he exposed a wrongdoing that could have repercussions for the entire health insurance industry.  Full Article | Slideshow 

  North Korean leader Kim Jong-il claps during a mass rally in Hamhung Square to celebrate the completion of the February 8 Vinalon Complex in Hamhung in South Hamgyong Province March 6, 2010 in this picture released by the North's KCNA news agency on March 7, 2010.  Credit: Reuters/KCNA

Is Kim having scary thoughts?

North Korea's Kim Jong-il is in one of the riskiest periods of his iron rule. Should the West be afraid?  Full Article 

Models of new iPhones with Chinese interface are shown during a promotional event in Hong Kong

Your iPhone may be sickening

A mysterious illness that left workers weak, shaky and in pain is traced back to a high-tech source: gadgets like the iPhone.  Full Article